Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

BACKGROUND: Kawasaki disease (KD) is an acute self-limiting inflammatory vasculitis affecting predominantly medium-sized arteries, particularly the coronary arteries. A number of recent studies conducted in different European countries have demonstrated alarmingly high coronary complications despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Eleftheriou, Despina, Moraes, Yolanda Collaco, Purvis, Cara, Pursell, Molly, Morillas, Marta Merida, Kahn, Robin, Mossberg, Maria, Kucera, Filip, Tulloh, Robert, Standing, Joseph F., Swallow, Veronica, McCormack, Rachael, Herberg, Jethro, Levin, Michael, Wan, Mandy, Klein, Nigel, Connon, Roisin, Walker, Ann Sarah, Brogan, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879235/
https://www.ncbi.nlm.nih.gov/pubmed/36703139
http://dx.doi.org/10.1186/s13063-022-07051-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879235/
https://www.ncbi.nlm.nih.gov/pubmed/36703139
http://dx.doi.org/10.1186/s13063-022-07051-9

Ejemplares similares